ESR2 and Parkinson disease: Molecular docking revealed a strong binding affinity between VitD and ESR2 (−8.6 kcal/mol), and Mendelian randomization analysis showed a significant protective effect of ESR2 activation on PD risk (OR = 0.46, 95% CI: 0.28–0.76, p = 0.002) [225].